Similar articles

• Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

  Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD. Currie CJ, et al. Lancet. 2010 Feb 6;375(9713):481-9. doi: 10.1016/S0140-6736(09)61969-3. Epub 2010 Jan 26. Lancet. 2010. PMID: 20110121
• Survival as a function of HbA(1c) in people with type 2 diabetes.

  Cruickshank JK. Cruickshank JK. Lancet. 2010 Apr 24;375(9724):1434; author reply 1434-5. doi: 10.1016/S0140-6736(10)60615-0. Lancet. 2010. PMID: 20417853 No abstract available.
• [Study finds more fatalities than in lax blood glucose control. Is HbA(1c) of 6.5% too low for the type 2 diabetes patient? (interview by Maria Weiss)].

  Haak T. Haak T. MMW Fortschr Med. 2008 Mar 6;150(10):17. MMW Fortschr Med. 2008. PMID: 18447283 German. No abstract available.
• Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

  Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A. Karagiannis T, et al. BMJ. 2012 Mar 12;344:e1369. doi: 10.1136/bmj.e1369. BMJ. 2012. PMID: 22411919
• Haemoglobin A1c analysis in the management of patients with diabetes: from chaos to harmony.

  Berg AH, Sacks DB. Berg AH, et al. J Clin Pathol. 2008 Sep;61(9):983-7. doi: 10.1136/jcp.2007.049205. J Clin Pathol. 2008. PMID: 18755722 Review.